American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 165-168 , July 2009

Renal Cell Carcinoma in Autosomal Dominant Polycystic Kidney Disease

  • Hiroaki Nishimura, MD

      Affiliations

    • Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan
    • Department of Urology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan
    • ,
  • Yoshifumi Ubara, MD

      Affiliations

    • Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan
    • Corresponding Author InformationAddress correspondence to Yoshifumi Ubara, MD, Nephrology Center, Toranomon Hospital Kajigaya, 1-3-1, Kajigaya, Takatsu, Kawasaki, Kanagawa, 213-8587, Japan
    • ,
  • Michio Nakamura, MD

      Affiliations

    • Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan
    • ,
  • Shohei Nakanishi, MD

      Affiliations

    • Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan
    • ,
  • Naoki Sawa, MD

      Affiliations

    • Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan
    • ,
  • Junichi Hoshino, MD

      Affiliations

    • Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan
    • ,
  • Tatsuya Suwabe, MD

      Affiliations

    • Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan
    • ,
  • Fumi Takemoto, MD

      Affiliations

    • Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan
    • ,
  • Masayuki Nakagawa, MD

      Affiliations

    • Department of Urology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan
    • ,
  • Kenmei Takaichi, MD

      Affiliations

    • Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan
    • ,
  • Shinji Tomikawa, MD

      Affiliations

    • Nephrology Center, Toranomon Hospital Kajigaya, Kanagawa, Japan

Received 20 September 2008 ,Accepted 30 January 2009.

References 

  1. Perrone RD, Ruthazer R, Terrin NC. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: Contribution of extrarenal complications to mortality. Am J Kidney Dis. 2001;38:777–784
  2. Ubara Y, Katori H, Tagami T, et al. Transcatheter renal arterial embolization therapy in a patient with polycystic kidney disease on hemodialysis. Am J Kidney Dis. 1999;34:926–931
  3. Ubara Y, Tagami T, Sawa N, et al. Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients. Am J Kidney Dis. 2002;39:571–579
  4. Keith VE, Torres VE, King BF, et al. Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1994;4:1661–1669
  5. Soderdahl DW, Thrasher JB, Hanberry KL. Bilateral renal cell carcinoma in autosomal dominant polycystic kidney disease. Am J Nephrol. 1997;17:96–99
  6. Jurgensen JS, Muller V, Kettritz U, Woywodt A, Gobel U, Luft FC. A malignant ‘incidentaloma’ in a patient with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 1999;14:490–492
  7. Hama Y, Kaji T, Ito K, et al. Erythropoietin-producing renal cell carcinoma arising from autosomal dominant polycystic kidney disease. Br J Radiol. 2005;78:269–271
  8. Lang EK, Davis R. Autosomal dominant polycystic kidney disease with renal cell carcinoma. J Urol. 2005;173:987
  9. Chang YL, Chung HJ, Chen KK. Bilateral renal cell carcinoma in a patient with autosomal dominant polycystic kidney disease. J Chin Med Assoc. 2007;70:403–405

 Originally published online as doi: 10.1053/j.ajkd.2009.01.270 on May 18, 2009.

PII: S0272-6386(09)00502-2

doi: 10.1053/j.ajkd.2009.01.270

American Journal of Kidney Diseases
Volume 54, Issue 1 , Pages 165-168 , July 2009

Article Tools

* Image Usage & Resolution